@article{36291dbc0f504c2982ef8e3cdee11859,
title = "An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome",
abstract = "This article presents an overview of four studies that evaluated a continuous oral contraceptive (OC) containing levonorgestrel (90 mcg) and ethinyl estradiol (20 mcg; LNG/EE) for managing premenstrual dysphoric disorder (PMDD) and premenstrual syndrome (PMS).",
keywords = "Antidepressive Agents, Clinical Trials as Topic, Contraceptives, Oral, Combined, Depressive Disorder, Ethinyl Estradiol, Female, Humans, Levonorgestrel, Placebo Effect, Premenstrual Syndrome",
author = "Freeman, {Ellen W} and Uriel Halbreich and Grubb, {Gary S} and Rapkin, {Andrea J} and Skouby, {Sven O} and Lynne Smith and Sebastian Mirkin and Constantine, {Ginger D}",
note = "Copyright {\textcopyright} 2012 Elsevier Inc. All rights reserved.",
year = "2012",
doi = "10.1016/j.contraception.2011.09.010",
language = "English",
volume = "85",
pages = "437--45",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier Inc",
number = "5",
}